[1]
V. Tsvetkov, “Factors for the Growth of Pharmaceutical Expenditures Reimbursed by Public Funds: Methods and Models for Reducing Them”, НТ, no. 2, pp. 277–310, Sep. 2009, Accessed: Jul. 23, 2026. Available: https://bjiep.e-dnrs.org/index.php/rp/article/view/5760